Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Oncoimmunology|March 26, 2013
Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patientsTrine Zeeberg Iversen, Marie Klinge Brimnes, Kirsten Nikolajsen, et al.
Plos One|April 28, 2012
Natural CD4+ T-cell responses against indoleamine 2,3-dioxygenaseShamaila Munir, Stine Kiaer Larsen, Trine Zeeberg Iversen, et al.
Cytotherapy|February 21, 2017
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II studyPer Kongsted, Troels Holz Borch, Eva Ellebaek, et al.
Oncoimmunology|October 21, 2016
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanomaTroels Holz Borch, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2016
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 RegimenRikke Andersen, Marco Donia, Eva Ellebaek, et al.
Journal of Translational Medicine|August 23, 2012
Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patientsEva Ellebaek, Trine Zeeberg Iversen, Niels Junker, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2013
Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an epitope derived from indoleamine 2,3 dioxygenaseTrine Zeeberg Iversen, Lotte Engell-Noerregaard, Eva Ellebaek, et al.
Translational Oncology|March 20, 2026
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohortMaj K Kjeldsen, Frederik Otzen Bagger, Henrik Roed, et al.
Cancer Research Communications|November 26, 2024
Beyond HRD Status: Unraveling Genetic Variants Impacting PARP Inhibitor Sensitivity in Advanced Ovarian CancerMaj K Kjeldsen, Morten Jørgensen, Dina Sofie B Grønseth, et al.
Pageof 2